|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 7.780 USD | +4.15% |
|
+4.99% | +27.96% |
| 10-19 | Exagen Insider Sold Shares Worth $269,791, According to a Recent SEC Filing | MT |
| 09-20 | Exagen Inc.(NasdaqGM:XGN) dropped from S&P Global BMI Index | CI |
Company Valuation: Exagen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 188 | 39.17 | 33.92 | 72.31 | 137.8 | 188.5 | - | - |
| Change | - | -79.17% | -13.39% | 113.18% | 90.55% | 36.78% | - | - |
| Enterprise Value (EV) | 188 | 39.17 | 33.92 | 72.31 | 137.8 | 188.5 | 188.5 | 188.5 |
| Change | - | -79.17% | -13.39% | 113.18% | 90.55% | 36.78% | 0% | 0% |
| P/E | -6.92x | -0.87x | -1.49x | -4.94x | -6.54x | -11.8x | -15.1x | -20.2x |
| PBR | 2.21x | 0.94x | 1.49x | 7.58x | 7.98x | 38.9x | -97.3x | - |
| PEG | - | -0x | 0x | 0.1x | -0.5x | 0.4x | 0.7x | 0.8x |
| Capitalization / Revenue | 3.89x | 0.86x | 0.65x | 1.3x | 2.07x | 2.55x | 2.31x | 2.05x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.55x | 2.31x | 2.05x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -32.4x | -123x | 59.5x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -15.7x | -22.4x | -46x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -13.4x | -25.1x | 85.7x |
| FCF Yield | -12% | -93.1% | -45.1% | -19.1% | -10.4% | -7.48% | -3.98% | 1.17% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.68 | -2.77 | -1.34 | -0.83 | -0.93 | -0.6583 | -0.515 | -0.385 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 48.3 | 45.56 | 52.55 | 55.64 | 66.58 | 73.91 | 81.51 | 91.97 |
| EBITDA 1 | -23.12 | -38.99 | -20.67 | -10.15 | -9.794 | -5.817 | -1.529 | 3.167 |
| EBIT 1 | -24.07 | -40.54 | -22.84 | -13.64 | -14.07 | -12.02 | -8.417 | -4.1 |
| Net income 1 | -26.85 | -47.39 | -23.69 | -15.12 | -19.95 | -15.93 | -13.38 | -9.65 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 11.630 | 2.400 | 1.990 | 4.100 | 6.080 | 7.780 | 7.780 | 7.780 |
| Nbr of stocks (in thousands) | 16,164 | 16,319 | 17,046 | 17,637 | 22,663 | 24,225 | - | - |
| Announcement Date | 3/22/22 | 3/20/23 | 3/18/24 | 3/11/25 | 3/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.82x | - | - | - | 188M | |
| 13.26x | 0.4x | 8.43x | 2.92% | 117B | |
| 14.99x | 1.88x | 9.38x | 0.69% | 97.42B | |
| -286.22x | 19.97x | -337.69x | -.--% | 59.22B | |
| 14.02x | 1.53x | 9.28x | 2.52% | 29.03B | |
| 23.2x | 2.17x | 12.44x | 0.88% | 26.86B | |
| 23.49x | 2.62x | 13.31x | 1.37% | 26.69B | |
| 7.96x | 1.43x | 6.5x | -.--% | 21.1B | |
| 30.58x | 5.46x | 22.21x | 2.29% | 20.61B | |
| 30.65x | 2.87x | 12.91x | 1.47% | 16.94B | |
| Average | -13.99x | 4.26x | -27.03x | 1.35% | 41.46B | |
| Weighted average by Cap. | -26.46x | 4.29x | -39.40x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- XGN Stock
- Valuation Exagen Inc.
Select your edition
All financial news and data tailored to specific country editions
